Assets Endring Dato
AbbVie USD 148.87B 12.65B 2024-03
Abbott USD 72.47B 887M 2024-03
Bayer EUR 119.88B 3.62B 2024-03
Bristol-Myers Squibb USD 99.03B 7.77B 2024-03
Catalent USD 9.88B 109M 2024-03
Corcept Therapeutics USD 655.94M 34.42M 2024-03
Dr.Reddys Laboratories INR 372.84B 24.75B 2023-12
Eli Lilly USD 63.94B 6.03B 2024-03
J&J USD 171.97B 5.9B 2024-03
Merck USD 105.85B 878M 2024-03
Nestle CHF 126.55B 5.05B 2023-12
Pacira USD 1.58B 8.93M 2024-03
Perrigo USD 10.64B 168.8M 2024-03
Pfizer USD 221.1B 6.07B 2024-03
Prestige Brands USD 3.32B 21.34M 2024-03
Reckitt Benckiser GBP 27.14B 379M 2023-12
Supernus Pharmaceuticals USD 1.3B 26.42M 2024-03
Teva Pharmaceutical Industries USD 42.77B 706M 2024-03
Xeris Pharmaceuticals USD 336.62M 14.01M 2024-03
Zoetis USD 14.35B 62M 2024-03



Perrigo Eiendeler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.